Philip F Halloran

31PUBLICATIONS
85CO-AUTHORS
Transplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical mycologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Apr 29, 2025
Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.

Matthias Diebold, Patrick T Gauthier, Katharina A Mayer

|Jul 18, 2024
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.

Fabian Halleck, Georg A Böhmig, Lionel Couzi

|Apr 17, 2024
Epithelial cell states associated with kidney and allograft injury.

Christian Hinze, Svjetlana Lovric, Philip F Halloran

|May 16, 2022
Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes.

Philip F Halloran, Katelynn S Madill-Thomsen, Shane Pon

|Jan 21, 2022
The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.

Philip F Halloran, Jeff Reeve, Katelynn S Madill-Thomsen

Pageof 6